Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 31, 2006

View Archived Issues

GRIMs: Novel cytokine-driven tumor suppressors

Anticoagulant proteins potentially useful for pneumonia and ARDS

Antigenics rounds up Q2 developments

Eisai reviews highlights of quarter

Antiallodynic effects of NAALADase inhibition in an in vivo model of neuropathic pain

IL-22: a novel target for autoimmune and inflammatory diseases

HIF-1alpha inhibition enhances antitumor activity of temozolomide

Oncolys BioPharma cleared to begin U.S. clinical trials of telomelysin

U. of Pittsburgh awarded NIAID grant for avian flu vaccine

Antisoma to study AS-1409 in renal cancer and melanoma

Agreement to study AE-37 in prostate cancer in Europe

Pharmexa cleared to begin phase Ib study of HIV vaccine EP-1090

Enrollment open in pivotal study of pralatrexate for peripheral T-cell lymphoma

U.S. DHS certifies BioThrax as approved product for homeland security

Bionomics profiles lead programs

BioDiem signs CRADA with CDC to develop bird flu vaccine

Caprospinol shows favorable results in acute toxicity study

Recent Cardiome patent describes new treatment options for cardiovascular disease

Chrysalin fails to meet primary endpoint in fracture repair

New agents for treating respiratory disorders reported in recent patent literature

Novel treatment options for inflammatory disorders disclosed in recent patents

Recent Synta patent describes novel immunosuppressant agents

German approval for Foster in asthma

Zensana NDA accepted for review

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
New assay for drug discovery against chemo-induced peripheral neuropathy
BioWorld Science
A group led by researchers at Boston Children’s Hospital established a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...